180 related articles for article (PubMed ID: 21818719)
1. [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].
Marschall U; Arnold B; Häuser W
Schmerz; 2011 Aug; 25(4):402-4, 406-10. PubMed ID: 21818719
[TBL] [Abstract][Full Text] [Related]
2. [Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010].
Häuser W; Marschall U; L'hoest H; Komossa K; Henningsen P
Schmerz; 2013 Aug; 27(4):380-6. PubMed ID: 23860633
[TBL] [Abstract][Full Text] [Related]
3. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
[TBL] [Abstract][Full Text] [Related]
4. Fibromyalgia syndrome: prevalence, pharmacological and non-pharmacological interventions in outpatient health care. An analysis of statutory health insurance data.
Sauer K; Kemper C; Glaeske G
Joint Bone Spine; 2011 Jan; 78(1):80-4. PubMed ID: 20674451
[TBL] [Abstract][Full Text] [Related]
5. Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study.
Sicras-Mainar A; Rejas J; Navarro R; Blanca M; Morcillo A; Larios R; Velasco S; Villarroya C
Arthritis Res Ther; 2009; 11(2):R54. PubMed ID: 19366441
[TBL] [Abstract][Full Text] [Related]
6. [High utilization of health care services by fibromyalgia patients].
Horndasch S
Schmerz; 2009 Feb; 23(1):70-1. PubMed ID: 19153777
[No Abstract] [Full Text] [Related]
7. Direct costs of Alzheimer's disease in Germany.
Kiencke P; Daniel D; Grimm C; Rychlik R
Eur J Health Econ; 2011 Dec; 12(6):533-9. PubMed ID: 20640868
[TBL] [Abstract][Full Text] [Related]
8. [Costs of ulcerative colitis within the German Statutory Health Insurance].
Prenzler A; Bokemeyer B; Mittendorf T; von der Schulenburg JM
Dtsch Med Wochenschr; 2010 Feb; 135(7):281-6. PubMed ID: 20146156
[TBL] [Abstract][Full Text] [Related]
9. [Cost of illness in Alzheimer's disease].
Kiencke P; Rychlik R; Grimm C; Daniel D
Med Klin (Munich); 2010 May; 105(5):327-33. PubMed ID: 20503006
[TBL] [Abstract][Full Text] [Related]
10. The German fibromyalgia consumer reports - a cross-sectional survey.
Häuser W; Jung E; Erbslöh-Möller B; Gesmann M; Kühn-Becker H; Petermann F; Langhorst J; Thoma R; Weiss T; Wolfe F; Winkelmann A
BMC Musculoskelet Disord; 2012 May; 13():74. PubMed ID: 22607517
[TBL] [Abstract][Full Text] [Related]
11. Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.
Gumà-Uriel L; Peñarrubia-María MT; Cerdà-Lafont M; Cunillera-Puertolas O; Almeda-Ortega J; Fernández-Vergel R; García-Campayo J; Luciano JV
BMC Fam Pract; 2016 Jun; 17():61. PubMed ID: 27245582
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and healthcare costs of patients with fibromyalgia syndrome.
Berger A; Dukes E; Martin S; Edelsberg J; Oster G
Int J Clin Pract; 2007 Sep; 61(9):1498-508. PubMed ID: 17655684
[TBL] [Abstract][Full Text] [Related]
13. Health economic consequences related to the diagnosis of fibromyalgia syndrome.
Annemans L; Wessely S; Spaepen E; Caekelbergh K; Caubère JP; Le Lay K; Taïeb C
Arthritis Rheum; 2008 Mar; 58(3):895-902. PubMed ID: 18311794
[TBL] [Abstract][Full Text] [Related]
14. [Health economic impact of heart failure: An analysis of the nationwide German database].
Zugck C; Müller A; Helms TM; Wildau HJ; Becks T; Hacker J; Haag S; Goldhagen K; Schwab JO
Dtsch Med Wochenschr; 2010 Apr; 135(13):633-8. PubMed ID: 20333603
[TBL] [Abstract][Full Text] [Related]
15. [Rehabilitation in geriatric patients after ischemic stroke--a comparison of 2 organisational systems in Germany using claims data of a statutory health insurance fund].
Abbas S; Ihle P; Hein R; Schubert I
Rehabilitation (Stuttg); 2013 Dec; 52(6):375-82. PubMed ID: 23824567
[TBL] [Abstract][Full Text] [Related]
16. Fibromyalgia-related costs and loss of productivity: a substantial societal burden.
Lacasse A; Bourgault P; Choinière M
BMC Musculoskelet Disord; 2016 Apr; 17():168. PubMed ID: 27084363
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and economic burden of pulmonary embolism in Germany.
Kröger K; Küpper-Nybelen J; Moerchel C; Moysidis T; Kienitz C; Schubert I
Vasc Med; 2012 Oct; 17(5):303-9. PubMed ID: 22751745
[TBL] [Abstract][Full Text] [Related]
18. Health economic burden of patients with restless legs syndrome in a German ambulatory setting.
Dodel R; Happe S; Peglau I; Mayer G; Wasem J; Reese JP; Giani G; Geraedts M; Trenkwalder C; Oertel WH; Stiasny-Kolster K
Pharmacoeconomics; 2010; 28(5):381-93. PubMed ID: 20297866
[TBL] [Abstract][Full Text] [Related]
19. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
[TBL] [Abstract][Full Text] [Related]
20. Processes of psoriasis health care in Germany--long-term analysis of data from the statutory health insurances.
Augustin M; Glaeske G; Schäfer I; Rustenbach SJ; Hoer A; Radtke MA
J Dtsch Dermatol Ges; 2012 Sep; 10(9):648-55. PubMed ID: 22525221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
